Global Custom Compounded Therapy Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Custom Compounded Therapy Industry Market Size Be by 2025?
Over the recent years, there has been a substantial growth in the size of the custom compounded therapy market. It is projected to expand from $5.52 billion as recorded in 2024 to $5.96 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.9%. The boom in the historic timeframe is associated with factors such as the escalating demand for personalized treatment, increase in chronic disease cases, growing pediatric and elderly populations, a surge in drug scarcity, and a rise in patient-specific allergies and intolerances.

What's the Long-Term Growth Forecast for the Custom Compounded Therapy Market Size Through 2029?
Predictions indicate a substantial increase in the custom compounded therapy market size, which is likely to reach $7.97 billion by 2029, registering a compound annual growth rate (CAGR) of 7.6%. The factors driving this projected growth include the proliferation of 3D printing technologies, enhanced healthcare facilities in developing markets, an uptick in the elderly population, and a heightened awareness of personalized healthcare solutions. The advancements in automated compounding systems, evolution of dosage forms tailored to individual patients, innovations in hormone replacement therapies, progress in pediatric compounding solutions, and the development of compounded veterinary medications are the major trends expected during this forecast period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/custom-compounded-therapy-global-market-report

What Are the Key Growth Drivers Fueling the Custom Compounded Therapy Market Expansion?
The surge in demand for personalized medicines is predicted to boost the progress of the custom compounded therapy market in the future. The term personalised medication is used to describe a medical treatment that's tailored to accommodate the unique characteristics, needs, and preferences of each patient, often relying on key elements like genetic, clinical, and lifestyle factors. The popularity of personalized medication is increasing because of its potential to enhance treatment efficiency and minimize harmful drug reactions by aligning the therapies with the individual patient's profiles. Custom compounded therapy plays a critical role in customizing medications by developing specific formulations that cater to each patient's distinctive needs, such as particular doses, combinations, and modes of delivery, assuring a more effective treatment and superior outcomes. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that in 2023, 16 new personalized treatments for patients with rare diseases received approval from the U.S. Food and Drug Administration, a remarkable rise from the six approved in 2022. Therefore, the escalated demand for personalized medicines is fuelling the expansion of the custom compounded therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28186&type=smp

What Are the Key Trends Driving Custom Compounded Therapy Market Growth?
Major players in the custom compounded therapy industry are putting their focus on creating ground-breaking products, including pharmaceutical compounding apparatuses, to improve precision, efficiency, and uniformity in the creation of personalized patient drugs. Pharmaceutical compounding devices are expert equipment made to precisely mix, measure and fabricate medications adjusted to the requirements of individual patients. For example, in December 2022, Baxter International Inc., a healthcare corporation from the United States specializing in medical goods and therapies, introduced an ExactaMix Pro Automated Compounder significantly increasing accuracy, productivity, and safeguarding patient safety in compounding. The company has built this upon its popular ExactaMix system, utilized in more than 1,000 pharmacies globally and accountable for compounding over 100 million bags. The ExactaMix Pro is the inaugural automated compounder to receive certification to the U.S. Food and Drug Administration (FDA)-recognized UL 2900-2-1 cybersecurity standard.

How Is the Custom Compounded Therapy Market Segmented?
The custom compounded therapy market covered in this report is segmented as

1) By Product Type: Hormone Replacement Therapy, Pain Management, Dermatology, Nutritional Supplements, Other Product Types
2) By Therapy Type: Intravenous (IV) Therapy, Topical Therapy, Oral Therapy, Subcutaneous Therapy
3) By Formulation: Injectable Formulation, Oral Formulation, Transdermal Formulation
4) By Therapeutic Applications: Oncology, Neurology, Cardiology, Endocrinology, Pain Management
5) By End-User: Hospitals, Clinics, Homecare Settings, Specialty Pharmacies

Subsegment:
1) By Hormone Replacement Therapy: Estrogen Therapy, Testosterone Therapy, Progesterone Therapy, Thyroid Hormone Therapy, Combination Hormone Therapy
2) By Pain Management: Analgesics, Anti-Inflammatory Compounds, Muscle Relaxants, Topical Pain Relief, Opioid-Based Compounds
3) By Dermatology: Anti-Acne Formulations, Anti-Fungal Treatments, Anti-Aging Creams, Topical Steroids, Moisturizers And Emollients
4) By Nutritional Supplements: Vitamins, Minerals, Amino Acids, Probiotics, Herbal Supplements
5) By Other Product Types: Veterinary Compounds, Pediatric Formulations, Allergen-Free Medications, Specialty Compounds

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28186&type=smp

Which Companies Are Leading the Charge in Custom Compounded Therapy Market Innovation?
Major companies operating in the custom compounded therapy market are Hikma Pharmaceuticals PLC, Fagron N.V., Nephron Pharmaceuticals Corporation, Belmar Pharmacy LLC, Empower Clinic Services LLC, Medisca Pharmaceutique Inc., Central Admixture Pharmacy Services Inc. (CAPS), Wedgewood Connect LLC, AnazaoHealth Corporation, Wells Pharmacy Network LLC, Institutional Pharmacy Solutions Inc., KRS Global Biotechnology Inc., Bennett Pharmaceuticals of America LLC, Annovex Pharma Inc., Bravado Pharmaceuticals LLC, Pencol Compounding Pharmacy Inc., Rx3 Compounding Pharmacy Inc., CareFirst Specialty Pharmacy LLC, Vertisis Custom Pharmacy LLC, FarmaKeio Pharmacy Network LLC.

Which Regions Are Leading the Global Custom Compounded Therapy Market in Revenue?
North America was the largest region in the custom compounded therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in custom compounded therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28186

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.